BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 203321)

  • 21. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclic nucleotide phosphodiesterase activity in midpiece and tail of buffalo spermatozoa and its role in sperm motility.
    Bhatnagar SK; Anand SR
    Biochim Biophys Acta; 1982 May; 716(2):133-9. PubMed ID: 6284248
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B; Luong HB
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
    Mullaney I; Clegg RA
    Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1977 Jan; 480(1):194-203. PubMed ID: 188479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
    Miot F; Erneux C
    Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the rabbit myometrium].
    Osipenko AA; Prishchepa LA; Kurskiĭ MD
    Ukr Biokhim Zh (1978); 1986; 58(4):26-31. PubMed ID: 3016961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of cyclic adenosine 3':5'-monophosphate in the genesis of catecholamine-induced tachycardia in isolated rabbit sinoatrial node.
    Taniguchi T; Fujiwara M; Ohsumi K
    J Pharmacol Exp Ther; 1977 Jun; 201(3):678-88. PubMed ID: 194027
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-Km cyclic AMP phosphodiesterase from human platelets. Stimulation of activity by phosphorylation of the enzyme and affinity labeling of the active site.
    Grant PG; DeCamp DL; Bailey JM; Colman RF; Colman RW
    Adv Second Messenger Phosphoprotein Res; 1992; 25():73-85. PubMed ID: 1313273
    [No Abstract]   [Full Text] [Related]  

  • 31. Uptake and metabolism of cyclic AMP in rabbit choroid plexus in vitro.
    Hammers R; Clarenbach P; Lindl T; Cramer H
    Neuropharmacology; 1977 Feb; 16(2):135-41. PubMed ID: 190555
    [No Abstract]   [Full Text] [Related]  

  • 32. Proteolytic activation of Ca2+-dependent cyclic nucleotide phosphodiesterase from Escherichia coli.
    Iwasa Y
    Horm Metab Res; 1981 Jul; 13(7):414-5. PubMed ID: 6268507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cyclic nucleotide phosphodiesterase of buffalo spermatozoa with sperm chromatin.
    Bhatnagar SK; Anand SR
    Biochim Biophys Acta; 1981 May; 674(2):212-24. PubMed ID: 6263350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of mammalian cyclic AMP phosphodiesterases by trypsin.
    Epstein PM; Pledger WJ; Gardner EA; Stancel GM; Thompson WJ; Strada SJ
    Biochim Biophys Acta; 1978 Dec; 527(2):442-55. PubMed ID: 215213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue.
    Küng W; Bechtel E; Geyer E; Salokangas A; Preisz J; Huber P; Torhorst J; Jungmann RA; Talmadge K; Eppenberger U
    FEBS Lett; 1977 Oct; 82(1):102-6. PubMed ID: 199454
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH; Herrington PT; Bocek RM
    Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
    Ho C; Teo TS; Desai R; Wang JH
    Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
    Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
    Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
    Chasin M; Harris DN
    Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.